APO-PRUCALOPRIDE 2 MG — DIN 02491605
PRUCALOPRIDE (PRUCALOPRIDE SUCCINATE) : 2 MG · APOTEX INC · TABLET · wholesale supply in Canada
Health Canada status: MARKETED
What is APO-PRUCALOPRIDE?
APO-PRUCALOPRIDE 2 MG contains PRUCALOPRIDE (PRUCALOPRIDE SUCCINATE) : 2 MG. It is listed in the Health Canada Drug Product Database under DIN 02491605, held by APOTEX INC, supplied as TABLET for ORAL administration. Health Canada currently lists it as marketed, status dated 27-Jan-2020. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
What is APO-PRUCALOPRIDE used for?
Treatment of chronic idiopathic constipation in adult female patients in whom laxatives failed to provide adequate relief. (Insufficient data for efficacy in males).
Authorized indication as written in the Health Canada product monograph. For healthcare professionals and licensed purchasers; this is not medical advice.
How much does Prucalopride cost around the world?
Prucalopride is listed on 4 of the national price registers Nexara ingests. Each country publishes on a different basis, so those figures are not comparable with one another — or with a Canadian wholesale price.
What a market publishes matters more than the number it publishes. Iceland publishes a max wholesale; Saudi Arabia publishes a public; United Kingdom publishes a hospital. Comparing an ex-factory ceiling against a pharmacy public price tells you nothing about either, and comparing either against a Canadian landed cost tells you less.
| Market | Price basis published there | Brands | Packs listed | Range |
|---|---|---|---|---|
| United States | acquisition | 2 | 22 | USD███.██ |
| Saudi Arabia | public | 4 | 7 | SAR███.██ |
| United Kingdom | hospital | 2 | 2 | GBP███.██ |
| Iceland | max wholesale | 1 | 1 | ISK███.██ |
32 pack listings across 9 brand entries and 4 price bases, refreshed 03 Sep 2026. Ranges span every Prucalopride pack in that market, so a high figure is usually a larger pack rather than the same product.
Canada publishes no comparable public list price. For a delivered Canadian price on a licensed account, verify your licence — it takes about a minute.
Is there a generic Prucalopride in Canada, and who makes it?
Every market authorization holder with a Canadian DIN for this molecule, and how many of their listings Health Canada currently shows as marketed.
6 holders have a Canadian DIN containing Prucalopride, across 12 DINs, of which 10 are currently marketed. Marketed count is the number that matters: an approval that is not marketed cannot be bought.
| Market authorization holder | DINs | Marketed | Brand names | Position |
|---|---|---|---|---|
| AMDIPHARM LIMITED | 2 | 2 | RESOTRAN | Sourceable in Canada |
| APOTEX INC | 2 | 2 | APO-PRUCALOPRIDE | Sourceable in Canada |
| JAMP PHARMA CORPORATION | 2 | 2 | JAMP PRUCALOPRIDE | Sourceable in Canada |
| NORA PHARMA INC | 2 | 2 | NRA-PRUCALOPRIDE | Sourceable in Canada |
| SANIS HEALTH INC | 2 | 2 | PRUCALOPRIDE | Sourceable in Canada |
| PHARMASCIENCE INC | 2 | 0 | PMS-PRUCALOPRIDE | No marketed DIN |
Health Canada’s Drug Product Database does not flag which listing is the originator and which are subsequent-entry products, so Nexara does not label them here. Interchangeability is determined provincially, not federally — confirm for your province before a formulary switch. Nexara can confirm which of these is actually obtainable, and on what lead time, per order.
How is it supplied and stored?
Pack configuration, storage class and the handling constraints that drive cold-chain planning. One DIN can cover more than one pack size, and the pack — not the DIN — is what gets priced, shipped and invoiced.
| Strength on the label | 2 MG |
|---|---|
| Dosage form | TABLET |
| Route | ORAL |
| Pack configuration (monograph) | Bottles of 100 tablets and blister packs of 28 tablets. |
| Storage | Not explicitly detailed in provided text snippet (Section 11 header present but content truncated), though typically 15-30°C for such products. |
Before an order line is unambiguous Nexara needs the strength, the pack size and the presentation, because this listing covers more than one of them.
Substance and classification
| Active substance | Prucalopride |
|---|---|
| ATC code | A06AX05 |
| AHFS class | 56:92.00 |
| Biosimilar biologic | No |
Health Canada record and identifiers
The regulatory facts straight from the Drug Product Database, plus every identifier form Nexara accepts on a purchase order. A DIN written without its leading zeros is the commonest reason an order line fails to match.
| DIN (8-digit, as used in ordering) | 02491605 |
|---|---|
| DIN (unpadded, as printed on some documents) | 2491605 |
| Brand name | APO-PRUCALOPRIDE |
| Generic / active ingredient | PRUCALOPRIDE (PRUCALOPRIDE SUCCINATE) : 2 MG |
| Market authorization holder | APOTEX INC |
| Health Canada schedule | Prescription |
| ATC code | A06AX05 |
| ATC anatomical main group | A — Alimentary tract and metabolism |
| ATC therapeutic subgroup | A06AX |
| Current status | MARKETED |
| Status date | 27-Jan-2020 |
| Original market date | 2020-01-27 00:00:00 |
| Status source | Live Health Canada DPD sync |
Verify on the primary sources
How is it administered?
Adults: 2 mg once daily. Elderly (>65 years): Start with 1 mg once daily, may increase to 2 mg. Discontinue if not effective within 4 weeks. Re-assess benefit at regular intervals.
Included because it drives pack selection and wastage. Consult the monograph.
Contraindications
Hypersensitivity; renal impairment requiring dialysis; intestinal perforation or obstruction; obstructive ileus; severe inflammatory conditions (Crohn’s, ulcerative colitis, toxic megacolon).
Warnings and precautions
Caution in severe/unstable organ disease; history of arrhythmias or ischemic heart disease; risk of suicidal ideation/behavior; potential for ischemic colitis; dizziness/fatigue may affect driving.
What can be used instead?
Alternatives on every axis a buyer actually considers — the same molecule in another presentation, the same class, an adjacent class, or a fixed-dose combination. Every row is led by the marketed DIN count, because that is what can be bought this week.
1 · Same molecule, other Canadian presentations
10 of 12 Canadian DINs for this molecule are currently marketed. Marketed products are listed first.
| Product | Strength | Form | Holder | Health Canada status | DIN |
|---|---|---|---|---|---|
| APO-PRUCALOPRIDE | 1 MG | TABLET | APOTEX INC | MARKETED | 02491591 |
| JAMP PRUCALOPRIDE | 1 MG | TABLET | JAMP PHARMA CORPORATION | MARKETED | 02493489 |
| JAMP PRUCALOPRIDE | 2 MG | TABLET | JAMP PHARMA CORPORATION | MARKETED | 02493497 |
| NRA-PRUCALOPRIDE | 1 MG | TABLET | NORA PHARMA INC | MARKETED | 02550377 |
| NRA-PRUCALOPRIDE | 2 MG | TABLET | NORA PHARMA INC | MARKETED | 02550385 |
| PRUCALOPRIDE | 1 MG | TABLET | SANIS HEALTH INC | MARKETED | 02559005 |
| PRUCALOPRIDE | 2 MG | TABLET | SANIS HEALTH INC | MARKETED | 02559013 |
| RESOTRAN | 1 MG | TABLET | AMDIPHARM LIMITED | MARKETED | 02377012 |
| RESOTRAN | 2 MG | TABLET | AMDIPHARM LIMITED | MARKETED | 02377020 |
| PMS-PRUCALOPRIDE | 2 MG | TABLET | PHARMASCIENCE INC | CANCELLED PRE MARKET | 02499959 |
2 · Same class — other molecules in ATC A06AX
| Molecule | Canadian brands | DINs | Marketed | Sourceable |
|---|---|---|---|---|
| Prucalopride | APO-PRUCALOPRIDE · JAMP PRUCALOPRIDE · NRA-PRUCALOPRIDE · PMS-PRUCALOPRIDE · +2 more | 12 | 10 | Yes |
| Linaclotide | CONSTELLA | 3 | 3 | Yes |
| Plecanatide | TRULANCE | 1 | 1 | Yes |
| Glycerol | GLY-RECTAL SUP POUR ADULTES · GLYCERIN LIQ · GLYCERIN LIQUID · GLYCERIN SUPPOSITORIES · +7 more | 11 | 0 | Not in Canada |
| Other Laxatives | DYCHOLIUM TABLET 300MG | 1 | 0 | Not in Canada |
| Lubiprostone | AMITIZA | 1 | 0 | Not in Canada |
| Tenapanor | IBSRELA | 1 | 0 | Not in Canada |
A molecule with zero marketed DINs cannot be sourced domestically, however many approvals it holds — if one of these sits on a formulary or in an older protocol, that is the line to check.
3 · Adjacent classes in ATC A06A
| ATC subgroup | Molecules | DINs | Marketed |
|---|---|---|---|
| A06AB | Bisacodyl · Bisacodyl, Combinations · Cascara · Cascara, Combinations · Castor Oil · +9 more | 239 | 25 |
| A06AA | Docusate Sodium · Docusate Sodium, Combinations · Liquid Paraffin · Liquid Paraffin, Combinations | 144 | 22 |
| A06AD | Lactulose · Macrogol · Macrogol, Combinations · Magnesium Oxide · Magnesium Sulphate · +5 more | 86 | 21 |
| A06AH | Methylnaltrexone Bromide · Naloxegol | 5 | 3 |
| A06AG | Bisacodyl · Combinations · Docusate Sodium, Incl Combinations · Sodium Phosphate | 7 | 1 |
| A06AC | Ispaghula (Psylla Seeds) · Ispaghula, Combinations · Linseed · Methylcellulose · Polycarbophil Calcium · +2 more | 79 | 0 |
Not clinical advice. These tables describe what can be supplied in Canada, not what should be prescribed. Substitution within or across classes is a prescriber and pharmacist decision, and interchangeability is determined provincially.
What else is APO-PRUCALOPRIDE called?
The same molecule, Prucalopride, is registered under other names elsewhere. Buyers and prescribers searching from outside Canada — or working from a foreign prescription or tender document — often know it by one of these:
| Name | Script | Registered in |
|---|---|---|
| Altan | Latin | Saudi Arabia |
| Conestal | Latin | Saudi Arabia |
| Resolor | Latin | Iceland |
Names are taken from national medicine registers and published price lists. A product registered abroad is not authorized for sale in Canada unless it holds its own DIN; import is possible only through the routes Health Canada permits.
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address. Patients and unlicensed buyers are routed to a partner pharmacy.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Why is there no price on this page?
Nexara quotes a delivered Canadian price per order, against a verified licence. Foreign list prices are published on incompatible bases and are not a guide to what any buyer can obtain here, so this page shows which markets list the molecule and on what basis, and nothing more.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.